DavidBSeiferMD

Summary

• I am very pleased to be part of the Yale Fertility Center. I look forward to providing the best clinical experience for each of my patients while utilizing one of the most advanced reproductive facilities in the U.S. My approach is to provide the most compassionate and contemporary infertility services available to meet the individual needs and personal values of my patients. Areas of special clinical interest include optimizing age-related infertility, pre-implantation genetic diagnosis, male factor infertility, recurrent pregnancy loss, polycystic ovarian syndrome and fertility preservation.
  
  My research includes the mechanisms of reproductive aging. This work has led to a simple blood test, antimullerian hormone (AMH), used worldwide today that helps determine the health of a woman’s ovaries, a rough estimate of her egg count and real time assessment of her biological clock.
  
  To learn more read: https://www.yalemedicine.org/stories/fertility-test/. or https://medicine.yale.edu/news/yale-medicine-magazine/overcoming-infertility/ or https://medicine.yale.edu/news/yale-medicine-magazine/a-grand-challenge-slowing-the-biological-clock/.
  
  Have been serving as Co-editor-in-chief of Reproductive Biology and Endocrinology since 2016, a peer reviewed journal in Reproductive Biology.
  
  Past president of the Society for Assisted Reproductive Technology (SART), the primary national organization that sets clinical and laboratory guidelines/standards for safety and quality metrics of the practice of ART in the US.
  
  Program Director of the Fellowship focused in Reproductive Endocrinology and Infertility based at Yale University School of Medicine. Responsible for the mentoring, advanced training and organizing of post-graduate physicians who become board eligible in the sub-specialty of REI after their 3 year experience at Yale.